Elimination of Fox Rabies from Belgium Using a Recombinant Vaccinia-Rabies Vaccine: An Update
peer reviewed ; To improve both safety and stability of the vaccines used in the field to vaccinate foxes against rabies by the oral route, a recombinant vaccinia virus, expressing the glycoprotein of rabies virus (VVTGgRAB) has been developed. VVTGgRAB innocuity was verified in target species and in domestic animals as well as in numerous wild animal species that could compete with the red fox in consuming vaccine baits in Europe. Oral immunization of foxes, by distributing VVTGgRAB vaccine-baits, was undertaken in the whole of the infected area of Belgium (10,000 km2). Five campaigns of fox... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journal article |
Erscheinungsdatum: | 1995 |
Verlag/Hrsg.: |
Elsevier
|
Schlagwörter: | Rabies / Fox / Vaccinia rabies vaccine / Life sciences / Veterinary medicine & animal health / Sciences du vivant / Médecine vétérinaire & santé animale |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26592879 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/247353 |